Dear Professor Roth,
Here at Stanford University School of Medicine we are working on an analysis of basal cell carcinoma. Sequencing of the tumors gives us small variant mutations, amplifications, and deletions. It is straightforward to use PyClone with the small variants because we have reference counts and variant counts. How do you recommend, if at all, that amplifications and deletions be incorporated into a PyClone analysis?
Sincerely yours, with appreciation and gratitude to you,
Luqman Mushila Hodgkinson, MS, PhD